THE ADMINISTRATION OF CHEMO-THERAPEUTIC AGENTS IN THE TREATMENT OF ADVANCED HEAD AND NECK CANCER.
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D001011:Aorta; D001012:Aorta, Abdominal; D044383:Black People; D002404:Catheterization; D005009:Ethoglucid; D005153:Facial Neoplasms; D005467:Floxuridine; D006257:Head; D006258:Head and Neck Neoplasms; D006801:Humans; D007269:Injections, Intra-Arterial; D007630:Kenya; D008727:Methotrexate; D009369:Neoplasms / Q000453:epidemiology* / Q000532:radiotherapy*; D009588:Nitrogen Mustard Compounds; D010166:Palliative Care; D013514:Surgical Procedures, Operative; D014116:Toxicology
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D009588:Nitrogen Mustard Compounds; D005467:Floxuridine; D005009:Ethoglucid; D008727:Methotrexate
ALKYLATING AGENTS; ANTINEOPLASTIC AGENTS; AORTA, ABDOMINAL; CATHETERIZATION; ETHOGLUCID; FACIAL NEOPLASMS; FLUORODEOXYURIDINE; HEAD; INJECTIONS, INTRA-ARTERIAL; KENYA; METHOTREXATE; NECK NEOPLASMS; NEGROES; NEOPLASM RADIOTHERAPY; NEOPLASM STATISTICS; NITROGEN MUSTARD COMPOUNDS; PALLIATIVE TREATMENT; SURGERY, OPERATIVE; TOXICOLOGIC REPORT